Taiwan FDA registration f546d34b75867600fa4de13890303c61
Quickeli Yazi type B sodium urine peptide test.
TW: 快得利 揣耶濟 B型鈉尿縮氨酸試驗。
Taiwan·Risk Class 2·Quidel Cardiovascular Inc.·Registered Feb 27, 2006 – Feb 27, 2026ExpiredRegistration details
- Analysis ID
- f546d34b75867600fa4de13890303c61
- Customs Code
- DHA00601605801
Company information
- Manufacturer
- Quidel Cardiovascular Inc.
- Manufacturer Country
- United States
- Authorized Representative
- BIO-CHECK LABORATORIES LTD.
Product details
- Intended Use
- This product is used in the Triage detector to rapidly quantify the detection of B-type sodium urine acetal in human EDTA whole blood or plasma.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1117 B type B natriuretic peptide test system
- Import Information
- import
Dates and status
- Registration Date
- Feb 27, 2006
- Expiry Date
- Feb 27, 2026
About this record
Access comprehensive regulatory information for Quickeli Yazi type B sodium urine peptide test. in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f546d34b75867600fa4de13890303c61 and manufactured by Quidel Cardiovascular Inc.. The authorized representative in Taiwan is BIO-CHECK LABORATORIES LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices